Q03181 |
PPARD_HUMAN |
Non-alcoholic fatty liver disease [ICD-11: DB92] |
Q03181 |
PPARD_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
Q03181 |
PPARD_HUMAN |
Autoimmune liver disease [ICD-11: DB96] |
Q03181 |
PPARD_HUMAN |
Hyper-lipoproteinaemia [ICD-11: 5C80] |
Q03181 |
PPARD_HUMAN |
Obesity [ICD-11: 5B80-5B81] |
Q03181 |
PPARD_HUMAN |
Alzheimer disease [ICD-11: 8A20] |
Q03181 |
PPARD_HUMAN |
Dyslipidemia [ICD-11: 5C80-5C81] |
Q03181 |
PPARD_HUMAN |
Metabolic disorder [ICD-11: 5C50-5D2Z] |
Q03181 |
PPARD_HUMAN |
Diabetes mellitus [ICD-11: 5A10] |
Q03181 |
PPARD_HUMAN |
Central nervous system disease [ICD-11: 8A04-8D87] |
Q96RI1 |
NR1H4_HUMAN |
Autoimmune liver disease [ICD-11: DB96] |
Q96RI1 |
NR1H4_HUMAN |
Cholelithiasis [ICD-11: DC11] |
Q96RI1 |
NR1H4_HUMAN |
Insomnia [ICD-11: 7A00-7A0Z] |
Q96RI1 |
NR1H4_HUMAN |
Osteoarthritis [ICD-11: FA00-FA05] |
Q96RI1 |
NR1H4_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
Q96RI1 |
NR1H4_HUMAN |
Non-alcoholic fatty liver disease [ICD-11: DB92] |
Q96RI1 |
NR1H4_HUMAN |
Chronic kidney disease [ICD-11: GB61] |
Q96RI1 |
NR1H4_HUMAN |
Skeletal anomaly [ICD-11: LD24] |
Q96RI1 |
NR1H4_HUMAN |
Hepatic fibrosis/cirrhosis [ICD-11: DB93] |
Q96RI1 |
NR1H4_HUMAN |
Hyper-lipoproteinaemia [ICD-11: 5C80] |
Q96RI1 |
NR1H4_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |